Bellevue Life Sciences Acquisition Corp. Unit
BLACU
BLACU was delisted on the 14th of February, 2025.
2 hedge funds and large institutions have $42.5K invested in Bellevue Life Sciences Acquisition Corp. Unit in 2024 Q1 according to their latest regulatory filings, with funds opening new positions, 1 increasing their positions, 0 reducing their positions, and 0 closing their positions.
3,545% more capital invested
Capital invested by funds: $1.17K → $42.5K (+$41.4K)
0% more funds holding
Funds holding: 2 → 2 (0)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CS
Clear Street
New York
|
+$39.3K |
Top Sellers
BLACU Hedge Fund Activity: Q1 2024 in Review
2 of the 6,942 institutional investors tracked by Wall St. Rank reported a position in Bellevue Life Sciences Acquisition Corp. Unit (BLACU) for Q1 2024, worth a combined $42.5K — up 3,545% from $1.17K a quarter earlier.
Fund positioning in BLACU was balanced in Q1 2024: 0 funds opened new positions, 0 closed out, 1 added to existing stakes and 0 trimmed.
The largest buyer was Clear Street, adding an estimated $39.3K.
- 2 institutional investors held Bellevue Life Sciences Acquisition Corp. Unit (BLACU) as of Q1 2024, unchanged from Q4 2023.
- Funds reported $42.5K of Bellevue Life Sciences Acquisition Corp. Unit stock for Q1 2024, up 3,545% quarter-over-quarter.
- 0 funds opened new Bellevue Life Sciences Acquisition Corp. Unit positions in Q1 2024 and 0 closed out.
- The largest Bellevue Life Sciences Acquisition Corp. Unit buyer in Q1 2024 was Clear Street, an estimated $39.3K added.
Based on aggregated 13F filings for Q1 2024.